Zobrazeno 1 - 10
of 647
pro vyhledávání: '"pulmonary arterial hypertension (pah)"'
Autor:
Jantaras Sengsim, Chodchanok Vijarnsorn, Prakul Chanthong, Paweena Chungsomprasong, Supaluck Kanjanauthai, Ploy Thammasate, Thita Pacharapakornpong, Nalin Chaiwangyen, Densiri Bositthipichet, Jarupim Soongswang, Teerapong Tocharoenchok, Ekarat Nitiyarom, Kriangkrai Tantiwongkosri, Thaworn Subtaweesin, Kritvikrom Durongpisitkul
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Pulmonary arterial hypertension (PAH) associated with congenital heart disease (PAH-CHD) is a consequence of unrepaired large systemic-to-pulmonary shunts. The long-term data of adult patients who have PAH-CHD with elevated pulmonary vascula
Externí odkaz:
https://doaj.org/article/9993885702774d3d97b7f380f4863243
Autor:
Meng Zhang, Haobo Li, Shuangshuang Ma, Xincheng Li, Linfeng Xi, Yishan Li, Zhu Zhang, Shuai Zhang, Qian Gao, Qiang Huang, Jun Wan, Wanmu Xie, Jifeng Li, Peiran Yang, Yunxia Zhang, Zhenguo Zhai
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background Identification and validation of potential biomarkers could facilitate the identification of pulmonary arterial hypertension (PAH) and thus aid to study their roles in the disease process. Methods We used the isobaric tag for rela
Externí odkaz:
https://doaj.org/article/a8612b9785b444da96075f22d5af6048
Autor:
Dandan Chen, Qi Jin, Lifan Yang, Xiaochun Zhang, Mingfei Li, Lei Zhang, Wenzhi Pan, Daxin Zhou, Junbo Ge, Lihua Guan
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Previous research has revealed the potential impact of circadian rhythms on pulmonary diseases; however, the connection between circadian rhythm-associated Thyrotroph Embryonic Factor (TEF) and Pulmonary Arterial Hypertension (PAH
Externí odkaz:
https://doaj.org/article/402b09486aca4dd2809e46b2d41b1679
Autor:
Nalin Chaiwangyen, Chodchanok Vijarnsorn, Paweena Chungsomprasong, Prakul Chanthong, Supaluck Kanjanauthai, Ploy Thammasate, Thita Pacharapakornpong, Densiri Bositthipichet, Jantaras Sengsim, Jarupim Soongswang, Teerapong Tocharoenchok, Ekarat Nitiyarom, Kriangkrai Tantiwongkosri, Thaworn Subtaweesin, Kritvikrom Durongpisitkul
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Pulmonary arterial hypertension (PAH) associated with congenital heart disease (PAH-CHD) is a complication that occurs after unrepaired significant systemic-to-pulmonary shunt. Treatment options for PAH-CHD-predominantly left-to-right (L-R)
Externí odkaz:
https://doaj.org/article/142adf22b6294ab68bd0f7c64d01c58b
Autor:
Tilmann Kramer, Phillip Nattmann, Felix Gerhardt, Patrycja Stafiej, Daniel Dumitrescu, Henrik tenFreyhaus, Max Wißmüller, Christopher Hohmann, Stephan Baldus, Stephan Rosenkranz
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1540-1552 (2024)
Abstract Aims In pulmonary arterial hypertension (PAH), upfront combination therapy with ERA and PDE5i is associated with a reduction in morbidity and mortality events and improves standard haemodynamics, but data remain limited. Aims of this study w
Externí odkaz:
https://doaj.org/article/f23f54b13e534e42bb0d15185320ae04
Publikováno v:
Life, Vol 14, Iss 10, p 1265 (2024)
Pulmonary hypertension (PH) is a severe and chronic disease characterized by increased pulmonary vascular resistance and remodeling, often precipitating right-sided heart dysfunction and death. Although the condition is progressive and incurable, cur
Externí odkaz:
https://doaj.org/article/d91b094975094067a1685931e192ab6a
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 21, Iss , Pp 200252- (2024)
Pregnancy complicated with pulmonary arterial hypertension (PAH) is a severe and dangerous condition for both the mother and the fetus. Pregnancy-specific alterations in the maternal cardiovascular system suggest that PAH in pregnancy may manifest mo
Externí odkaz:
https://doaj.org/article/97f5dd70943944bc9a47c01f94cb8d93
Autor:
Yi-Chia Wu, Wei-Ting Wang, Ming-Chun Yang, Yu-Tsun Su, Jwu-Lai Yeh, Jong-Hau Hsu, Jiunn-Ren Wu
Publikováno v:
Biological Research, Vol 56, Iss 1, Pp 1-16 (2023)
Abstract Background Abnormal remodeling of the pulmonary vasculature, characterized by the proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) along with dysregulated glycolysis, is a pathognomonic feature of pulmonary arte
Externí odkaz:
https://doaj.org/article/cc7bb2c564ff45e18571fe0ff1d3f604
Publikováno v:
Polish Journal of Microbiology, Vol 72, Iss 2, Pp 143-154 (2023)
Both pulmonary arterial hypertension (PAH) and chronic obstructive pulmonary disease (COPD) are risk factors for coronavirus disease 2019 (COVID-19). Patients with lung injury and altered pulmonary vascular anatomy or function are more susceptible to
Externí odkaz:
https://doaj.org/article/6dd10139cbd54f978ee3807939c8d669
Autor:
Manuela Iseppi, Giulio Savonitto, Alberto Tommasini, Alessia Pin, Gianfranco Sinagra, Davide Stolfo
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract We report the first known case of PAMI syndrome associated with pulmonary arterial hypertension (PAH) with a positive response to cyclophosphamide and pulmonary vasodilators. The patient's history began at 7 months with severe pancytopenia a
Externí odkaz:
https://doaj.org/article/86f55b90a9a54d8f82e573da0dfbf075